Zentiva Continues Its Expansion In Oncology With The Launch Of ALYMSYS® (bevacizumab) In 21 Countries Across Europe

Zentiva and mAbxience announce their collaboration for the launch of the ALYMSYS® (bevacizumab) following its European Marketing Authorisation on March 26th. The EC approval is based on a comprehensive clinical and scientific … Read More